
Cefika S 1000mg/500mg Injection
Marketer
Stadchem Of India
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Cefika S 1000mg/500mg Injection
Cefika S Injection (1000 mg/500 mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a doctor's guidance; consistent adherence to the prescribed regimen is crucial, even with symptom improvement, as premature cessation can reduce effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration promote faster recovery. Your doctor may order blood tests and other assessments to monitor treatment efficacy.
Uses of Cefika S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Cefika S 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Cefika S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefika S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefika S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefika S 1000 mg/500 mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefika S 1000 mg/500 mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefika S 1000 mg/500 mg injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingCAUTION
Administering Cefika S 1000 mg/500 mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefika S 1000 mg/500 mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefika S 1000 mg/500 mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Cefika S 1000 mg/500 mg Injection to individuals with severe hepatic impairment requires careful monitoring. Dosage modification of Cefika S 1000 mg/500 mg Injection may be necessary. Physician consultation is advised. Altering the Cefika S 1000 mg/500 mg Injection dosage is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefika S 1000mg/500mg Injection :
Should you forget a scheduled dose of Cefika S 1000 mg/500 mg Injection, seek immediate medical advice.
Facts to Know About Cefika S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
